Fatty liver disease provides critical “building blocks” that allow liver cancer cells to grow more aggressively, according to research from Belgian scientists. The study indicates that the metabolic environment of a fatty liver enables cancer cells to synthesize the lipids and proteins necessary for rapid proliferation and metastasis.
Researchers from the KU Leuven and the University Hospital Gasthuis Sint-Jan in Bruges identified that hepatocellular carcinoma (HCC) cells hijack the metabolic processes of a steatotic (fatty) liver. This process allows tumors to thrive in conditions that would typically inhibit growth in a healthy liver, significantly increasing the malignancy of the cancer.
The findings highlight a direct link between Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)—formerly known as Non-Alcoholic Fatty Liver Disease (NAFLD)—and the acceleration of liver cancer. This suggests that managing liver fat is not merely about preventing the onset of cancer, but about limiting its aggressiveness once a tumor has formed.
How does a fatty liver accelerate cancer growth?
The Belgian research team found that cancer cells in a fatty liver utilize the excess lipids available in the surrounding tissue to fuel their own growth. In a healthy liver, cells maintain a strict balance of lipids; however, in a fatty liver, the abundance of fats acts as a fuel source for malignant cells.
According to the study, these “building blocks” allow the cancer to build new cell membranes more quickly and sustain the high energy demands of rapid division. This metabolic adaptation makes the tumors more resistant to certain treatments and more likely to spread to other parts of the body.
This mechanism explains why patients with MASLD often face a more challenging prognosis. The synergy between the metabolic dysfunction of the liver and the genetic mutations of the cancer creates a “permissive environment” that promotes tumor progression.
What are the signs of a fatty liver?
Early-stage fatty liver often presents no symptoms, which is why it is frequently detected during routine blood tests or imaging for other conditions. As the condition progresses to steatohepatitis (inflammation of the liver), patients may experience fatigue, a dull ache in the upper right side of the abdomen, or unexplained weight loss.
Medical professionals typically identify liver health through several diagnostic markers:
- Blood Tests: Elevated levels of liver enzymes, such as ALT (alanine aminotransferase) and AST (aspartate aminotransferase), can indicate liver cell damage.
- Imaging: Ultrasound, CT scans, or MRI can detect the accumulation of fat in the liver parenchyma.
- FibroScan: A specialized ultrasound technique used to measure liver stiffness and the percentage of fat (CAP score).
- Biopsy: The gold standard for confirming the stage of inflammation and the presence of fibrosis.
Who is most at risk for MASLD?
The risk of developing a fatty liver is closely tied to metabolic syndrome. According to the Mayo Clinic, the primary risk factors include obesity, type 2 diabetes, and high levels of triglycerides in the blood.
Insulin resistance plays a central role in this process. When the body cannot effectively use insulin, fats are diverted to the liver, where they accumulate. This accumulation triggers oxidative stress and inflammation, which can eventually lead to cirrhosis and hepatocellular carcinoma.
While traditionally associated with diet and lifestyle, some genetic predispositions also contribute to how the liver processes fats, making some individuals more susceptible to steatosis even at lower body weights.
How can liver health be improved?
The consensus among hepatologists is that lifestyle modification is the most effective way to reverse or manage fatty liver. Because the liver has a high capacity for regeneration, reducing the fat load can slow or even stop the progression toward cancer.
Key interventions include:
- Weight Reduction: Gradual weight loss of 7% to 10% of total body weight is often cited by clinicians as the threshold required to reduce liver inflammation and improve insulin sensitivity.
- Dietary Changes: Reducing the intake of refined sugars, particularly fructose, which is processed directly by the liver and contributes to fat buildup.
- Physical Activity: Both aerobic and resistance training help the body utilize stored fats and improve glucose metabolism.
- Alcohol Cessation: Avoiding alcohol is critical, as ethanol adds further toxic stress to a liver already struggling with metabolic fat.
For patients with advanced MASLD, doctors may prescribe medications to manage underlying conditions like diabetes or high cholesterol, though specific pharmacological treatments for steatosis are still undergoing rigorous clinical trials.
Why this research changes the approach to liver cancer
Previously, liver cancer was often viewed primarily as a result of chronic hepatitis B or C infections. This Belgian research shifts the focus toward the metabolic environment. It suggests that the “soil” (the fatty liver) is just as important as the “seed” (the cancer cell).
If the metabolic building blocks can be restricted, it may be possible to “starve” the cancer or make it more susceptible to chemotherapy and targeted therapies. This opens the door for combined treatment strategies where metabolic management is paired with oncological intervention.
The study emphasizes that screening for fatty liver in high-risk populations—specifically those with obesity and diabetes—is a critical preventative measure against aggressive liver cancer.
Further clinical trials are expected to investigate whether specific metabolic inhibitors can block the cancer cells’ ability to use these liver fats, potentially leading to a new class of therapies for HCC patients.
Patients are encouraged to consult their primary care physician for a liver function panel if they have risk factors associated with metabolic syndrome. Share this article to help others understand the link between metabolic health and cancer prevention.